Thomas Hefferon > Goodwin > Washington DC, United States > Lawyer Profile
Goodwin Offices
1900 N Street NW
Washington, District of Columbia 20036
United States
Thomas Hefferon
Position
Partner
Career
Tom Hefferon, partner and former co-chair of Goodwin’s Financial Industry practice, focuses his practice on government enforcement and civil litigation matters, with particular emphasis on the banking and consumer financial services industries. Tom also frequently provides compliance advice and litigation risk analysis to industry clients.
Education
JD, 1986, University of Chicago (magna cum laude) / BA, 1982, Trinity College (magna cum laude)
Lawyer Rankings
United States > Dispute resolution > Financial services litigation
(Hall of Fame)Goodwin is well-established in the consumer finance and regulatory space, handling a range of complex class and enforcement actions. Allison Schoenthal leads the group in New York, with a favorable track record in litigation representation whilst Washington’s Matthew Sheldon focuses on aiding financial institutions facing government investigations. Also in Washington is Thomas Hefferon
, a leading consumer finance litigator with experience handling MDLs, and federal and state appeals.
Lawyer Rankings
- Hall of Fame United States > Dispute resolution > Financial services litigation
- Financial services litigation United States > Dispute resolution
Top Tier Firm Rankings
- Industry focus > Cannabis
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Dispute resolution > E-discovery
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Intellectual property > Patents: litigation (full coverage)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Shareholder activism
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Capital markets: debt offerings
- International trade and national security > CFIUS
- Finance > Commercial lending
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade and national security > Customs, export controls and economic sanctions
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Intellectual property > Patents: litigation (International Trade Commission)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Healthcare > Service providers
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Real estate > Real estate finance
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Finance > Financial services regulation